Magnetic Resonance Evaluation of Tissue Iron Deposition and Cardiac Function in Adult Regularly Transfused Thalassemia Intermedia Compared with Thalassemia Major Patients.

: This multicenter, retrospective, population-based, matched-cohort study compared clinical characteristics and magnetic resonance imaging (MRI) findings, including hepatic, pancreatic, and cardiac iron levels and cardiac function, between 135 adult regularly transfused thalassemia intermedia (TI) patients (44.73 ± 12.16 years, 77 females) and 135 age- and sex-matched thalassemia major (TM) patients (43.35 ± 9.83 years, 77 females), enrolled in the Extension-Myocardial Iron Overload in Thalassemia Network. The MRI protocol included the quantification of hepatic, pancreatic, and cardiac iron levels (R2* technique), the assessment of biventricular function parameters (cine images), and the detection of replacement myocardial fibrosis (late gadolinium enhancement technique). Age, sex, frequency of splenectomy and chelation, and serum ferritin levels were not significantly different ( > 0.05) between the two groups, but TI patients started regular transfusions significantly later ( < 0.0001) and showed significantly lower pre-transfusion hemoglobin levels ( = 0.005). No difference was found in hepatic iron levels ( = 0.853). TI patients exhibited significantly lower pancreatic R2* values ( < 0.0001), also correcting for the duration of regular transfusions, and significantly lower cardiac R2* values ( < 0.0001). In the receiver operating characteristic analysis, pancreatic iron was the strongest discriminator between the two diseases. Left and right ventricular end-diastolic volume indexes were significantly higher in TI than in TM patients ( = 0.003 and = 0.046, respectively), but the correction for the duration of regular transfusions removed the disease-specific differences ( > 0.05). Left ventricular (LV) mass index was significantly higher in TI ( = 0.049), while no difference ( > 0.05) was found in biventricular ejection fractions and replacement myocardial fibrosis. TI patients showed lower pancreatic and cardiac iron burden and more pronounced LV hypertrophy. These differences could not be explained by the different duration of the transfusional regimen.